本草纲目

李时珍 (Lǐ Shízhēn, 1518–1593) was a physician from Qizhou 蕲州 in Huguang province (modern Hubei 湖北). He came from a medical family — his father was a local physician — and grew up immersed in practical pharmacological knowledge that sat at some distance from the classical textual tradition. He twice failed the provincial civil service examinations and in his late twenties turned fully toward medicine, studying under his father and then practicing independently. His dissatisfaction with existing pharmacopoeias was the seed of the Bencao Gangmu: he found the available references riddled with errors, contradictions, and misidentifications — plants confused with each other, dosage instructions copied without verification, mythological claims treated as clinical fact alongside genuine observation.

In 1552, at the age of thirty-four, he began the project that would consume the next twenty-seven years of his life. He read more than 800 previous texts, ranging from medical classics to agricultural manuals to alchemical treatises. He traveled extensively through the mountains of Hubei, Jiangxi, and Guangdong, collecting specimens, interviewing farmers, fishermen, hunters, and miners about plants, animals, and minerals they encountered. He grew herbs in his garden, tested preparations on patients, and personally verified — or debunked — received claims. The manuscript went through three complete revisions before he considered it finished. He died in 1593, a year before the first printing in Nanjing. He never held a court position; his patronage came from a brief appointment as physician to the court of Chu in Wuhan, where access to the prince's library gave him crucial textual resources. The Bencao Gangmu was very nearly lost — a first-edition copy was among the materials destroyed by later political upheaval, and surviving first editions are extremely rare.

The 本草纲目 (Běncǎo Gāngmù) — the title translates roughly as "Compendium of Materia Medica" or "Outline of the Roots and Herbs" — comprises 52 volumes (卷 juàn) divided into 16 parts (部 bù). It contains 1,892 drug entries (药物 yàowù), of which 374 were described for the first time by Li himself. For each entry, Li provides a standardized set of information organized under specific headings: the drug's name and name variants, a critique of previous descriptions, a physical description and where to find it, the drug's properties (flavor, temperature, toxicity), and its clinical indications. The name entries alone are a lexicographic achievement — Li traces the etymology of each drug name, documents regional variants and synonyms, and corrects misidentifications propagated by earlier authors.

The work also contains 11,096 prescriptions (处方 chǔfāng) — both classical formulas from earlier texts and practical remedies Li collected from practitioners and laypeople during his travels. These represent a comprehensive snapshot of Chinese pharmacological practice across all social levels in the mid-Ming period. The 1,109 illustrations commissioned for the work (most of which survive) are competent botanical and zoological drawings that, while not approaching the precision of European botanical illustration of the same period, are sufficient for identification purposes and represent a significant effort to ground the text in visual documentation. A complete set of illustrations took up a separate fascicle.

Li Shizhen's classification system was a significant departure from the earlier "three grades" structure that had organized Chinese pharmacopoeias since the Han dynasty — a hierarchy of superior, middle, and inferior drugs based on toxicity and tonic properties rather than on the nature of the substance itself. Li reorganized around the nature of the drug: what it physically is, from the most basic (water, fire, earth, minerals) to the most complex (mammals, humans). Within the plant sections, he organized by growth form and habitat. This is not Linnaean taxonomy — it is not based on reproductive morphology — but it represents a principled attempt to organize natural diversity by observable characteristics rather than by therapeutic value, which was a genuine methodological advance.

Within each entry, Li is notably willing to criticize received authority. He explicitly debunks myths — the claim that the rhinoceros horn can detect poison by causing a cup to bubble, for example, he dismisses as untested folklore. He notes when he could not personally verify a description. He describes his own field observations and distinguishes them from information received secondhand. This evidential self-consciousness — the practice of marking the distinction between direct observation and received tradition — is one of the features that has led historians of science to compare the Bencao Gangmu favorably with European natural history of the same period.

The Bencao Gangmu reached Europe in stages. A partial Latin translation of selected entries was published by the Jesuit missionary Michael Boym in his Flora Sinensis (1656). A more substantial engagement came through the German physician Engelbert Kaempfer, who studied Chinese medicine in Japan in the 1690s and brought descriptions of numerous drugs back to Europe. By the early eighteenth century, enough of the text had circulated that it was known to major European naturalists. Carl Linnaeus — the father of the modern taxonomic system — explicitly references Chinese botanical knowledge in several of his species descriptions, and historians have documented his direct use of information derived from the Bencao Gangmu tradition for several Asian plants.

Charles Darwin cited the Bencao Gangmu twice in The Variation of Animals and Plants under Domestication (1868), using Li's observations on the domestic goldfish and on the diversity of cultivated plants as evidence for his arguments about artificial selection. Darwin's citations are an index of the text's reputation in Victorian scientific circles: he had access to a French translation (by Stanislas Julien, 1855) and treated it as a reliable source of natural historical data. The Bencao Gangmu is thus one of the relatively rare pre-modern non-European texts to have had a documented influence on the development of Western evolutionary biology.

In the twentieth century the text has been the starting point for multiple pharmaceutical discoveries beyond artemisinin: compounds derived from plants documented by Li include huperzine A (from club moss, now in clinical trials for Alzheimer's disease), berberine (from coptis rhizome, documented antibacterial and anti-diabetic properties), and triptolide (from thunder god vine, under investigation as an anti-inflammatory and anti-cancer agent). The Bencao Gangmu functions, in this respect, as a pre-screened library of bioactive compounds: two thousand years of clinical observation have identified which plants produce physiologically significant effects; the task of modern pharmacology is to identify which effects are real, which mechanisms produce them, and whether they can be isolated and standardized.